34 292

Cited 17 times in

Down-regulation of MHC class I expression in human neuronal stem cells using viral stealth mechanism.

Lee, EM; Kim, JY; Cho, BR; Chung, WK; Yoon, BW; Kim, SU; Lee, BC; Hwang, WS; Moon, SY; Lee, JS; Ahn, C
Biochemical and biophysical research communications, 326(4):825-835, 2005
Journal Title
Biochemical and biophysical research communications
Due to their unique capacity for self-renewal in addition to their ability to differentiate into cells of all neuronal lineages, neuronal stem cells (NSCs) are promising candidates for cell replacement therapy in neuronal injury and neurodegenerative diseases. However, there are few studies on immune rejection, which is one of the main problems facing successful stem cell therapy. In order to determine if human NSC might be rejected after transplantation the MHC expression level was examined in the HB1.F3 cell line, which has previously been shown to exhibit NSC properties. The results showed low expression levels of the MHC class I molecules on the surfaces of these cells. A dramatic increase in the MHC class I expression level was observed when the cells were treated with IFN-gamma, TNF-alpha, and IL-1beta, alone or in combination. The maximum induction of MHC class I protein expression was observed at above 20ng/ml IFN-gamma 48h after the treatment. The apparent additive effects of TNF-alpha and IL-1beta in combination on the maximum induction of MHC class I expression exerted by IFN-gamma treatment were not observed. The MHC class I levels elevated by IFN-gamma were sustained for 72h after withdrawing the IFN-gamma. Therefore, this study introduced human cytomegalovirus (hCMV) US genes, which are known to be able to reduce the MHC class I expression level on the cell surface after infection, into HB1.F3 cells. The cells transfected with the hCMV US2, US3, US6 or US11 genes showed 20-50% reduction in the MHC class I expression level compared with the mock-transfected cells. These results suggest that NSC expresses high levels of the MHC class I proteins, and unless they are modified, might be rejected upon transplantation. In addition, the various viral stealth mechanisms can be exploited for stem cell transplantation.
MeSH terms
Cell LineCytomegalovirus/geneticsCytomegalovirus/metabolism*Down-Regulation/drug effectsDown-Regulation/immunologyFeasibility StudiesGenetic Enhancement/methodsHistocompatibility Antigens Class I/immunologyHistocompatibility Antigens Class I/metabolism*HumansMembrane Glycoproteins/geneticsMembrane Glycoproteins/immunologyMembrane Glycoproteins/metabolism*Neurons/cytologyNeurons/immunologyNeurons/metabolism*Stem Cells/cytologyStem Cells/immunologyStem Cells/metabolism*Transfection/methods*Viral Proteins/geneticsViral Proteins/immunologyViral Proteins/metabolism*
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Neurology
AJOU Authors
김, 승업
Full Text Link
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.